IRIS
CONTE, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.722
EU - Europa 4.669
AS - Asia 830
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 9
OC - Oceania 1
Totale 10.251
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.709
IE - Irlanda 1.563
UA - Ucraina 869
GB - Regno Unito 690
CN - Cina 425
IT - Italia 407
DE - Germania 392
SE - Svezia 265
FI - Finlandia 215
SG - Singapore 206
TR - Turchia 158
GR - Grecia 114
BE - Belgio 39
FR - Francia 37
RU - Federazione Russa 34
CZ - Repubblica Ceca 23
IR - Iran 13
CA - Canada 10
KR - Corea 8
EU - Europa 7
NL - Olanda 6
ES - Italia 5
SC - Seychelles 5
CL - Cile 4
JP - Giappone 4
HK - Hong Kong 3
IN - India 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EG - Egitto 2
HU - Ungheria 2
KE - Kenya 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
VN - Vietnam 2
AR - Argentina 1
AU - Australia 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BR - Brasile 1
CH - Svizzera 1
CU - Cuba 1
DK - Danimarca 1
HR - Croazia 1
ID - Indonesia 1
KZ - Kazakistan 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 10.251
Salva come PNG Salva come JPEG
Città #
Dublin 1.562
Jacksonville 1.316
Chandler 957
Princeton 243
Medford 226
Boardman 161
Ann Arbor 158
San Mateo 149
Roxbury 131
Singapore 106
Beijing 99
Wilmington 98
Woodbridge 94
New York 65
Bremen 60
Nanjing 54
Jinan 49
Caserta 47
Brussels 38
Des Moines 35
Saint Petersburg 32
Norwalk 28
Cambridge 27
Mountain View 26
Shenyang 26
Houston 23
Brno 22
Zhengzhou 21
Ashburn 20
Napoli 17
Milan 16
Hangzhou 13
Ningbo 13
Rome 13
Guangzhou 12
Naples 12
Taiyuan 11
Taizhou 11
Auburn Hills 10
Düsseldorf 10
Tianjin 10
Munich 9
Nanchang 9
Redwood City 9
Zanjan 9
Changsha 8
Jiaxing 8
Seattle 8
Bologna 7
Castel Volturno 7
Helsinki 7
Los Angeles 7
Turin 7
Florence 6
Haikou 6
Kunming 6
Ottawa 6
Groningen 5
Lanzhou 5
Palermo 5
Shanghai 5
Cantù 4
Fairfield 4
Genova 4
Hanover 4
Hebei 4
Torino 4
Cattolica 3
Chicago 3
Dearborn 3
Modena 3
Padova 3
Potenza 3
Sacramento 3
Santiago 3
Verona 3
Aci Catena 2
Andover 2
Anzio 2
Bitlis 2
Brusciano 2
Cagliari 2
Calgary 2
Calmasino 2
Castelnuovo Rangone 2
Catania 2
Dong Ket 2
Giugliano in Campania 2
Halle 2
Hong Kong 2
Leawood 2
Lima 2
Limatola 2
Madrid 2
Managua 2
Nairobi 2
Pavia 2
Pessac 2
Sant'Egidio alla Vibrata 2
Seregno 2
Totale 6.259
Salva come PNG Salva come JPEG
Nome #
Ruolo del refilling plasmatico dopo dialisi alternativa: valutazione dei dati bioimpedenzometrici 135
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 115
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 90
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 78
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 76
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 72
A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in chronic renal insufficiency (UBI) Study. J Nephrol 2011 Aug 23.0. doi: 10.5301/jn.5000014. Epub ahead of print 71
[Anti-diabetics and chronic kidney disease] 69
Daily nutrient intake in hemodialysis. 68
Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects 66
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure 66
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 66
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 66
Amino acid loss during dialysis treatment 66
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 65
Epidemiology of chronic kidney disease in Italy: the CARHES study 65
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 65
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 65
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 63
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 61
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 61
Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat 61
Acute renal and immunological effects of low-dose cyclosporin in humans 60
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 60
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 59
Management of hypertension in chronic kidney disease: the Italian multicenter study. 57
Epidemiology of chronic kidney disease in Italy. J Nephrol 2010;23 (Suppl 15):S16-22 57
Clinical management of the patient affected with acute renal failure (ARF) secondary to volume depletion 56
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 56
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 55
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 55
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 55
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 55
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 55
Effects of efficiency and length of acetate-free biofiltration session on post-dialysis solutes rebound 55
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question 55
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 55
Management of hypertension in chronic kidney disease 54
Disfunzione renale nell’anziano: processo fisiologico o malattia? 54
Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability? 54
Acute effects of cyclosporine on glomerular dynamics--micropuncture study in the rat 54
Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10 year follow-up 54
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 53
Heart Failure in chronic kidney disease: from epidemiology to therapy. 53
Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care 53
Acute renal failure of unknown origin. Don't forget renal tuberculosis 53
Epidemiology of CKD Regression in Patients under Nephrology Care 53
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 52
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 52
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 52
Acute cyclosporine A nephrotoxicity 52
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 52
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 52
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 51
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 51
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 51
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 51
Reversibility of acute cyclosporine renal impairment by dopamine in healthy subjects 51
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. 51
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 51
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 50
Stability of target hemoglobin levels during the first year of epoetin treatment in CKD patients. 50
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 50
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 50
A new diuretic: the Atrial Natriuretic Peptide 50
Manuale di Terapia delle Malattie Renali 50
[Iron deficiency in ND-CKD: from diagnosis to treatment] 50
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 49
Effects of a two-month treatment with low oral doses of cyclosporin on renal function 49
Hyponatremia secondary to inappropriate antidiuretic hormone secretion. 49
Waist: hip ratio is a better predictor of cardiovascular risk than BMI in patients with moderate CKD 49
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 49
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 49
Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study 48
Intradialytic changes of plasma amino acid levels: effect of hemodiafiltration with endogenous reinfusion versus acetate-free biofiltration 48
Epidemiology of chronic kidney disease in Italy 48
Effetti della infusione di dopamina sulla nefrotossicità acuta indotta dalla ciclosporina A 48
[Epidemiology and prognosis of chronic kidney disease in Italy] 48
Epoetin therapy and hemoglobin level variability in non-dialysis CKD patients 47
Sodium/Glucose Cotransporter 2 Inhibitors and Prevention of Diabetic Nephropathy: Targeting the Renal Tubule in Diabetes 47
Effects of age on hypertensive status in patients with chronic kidney disease 47
Dietary compliance to a low protein and phosphate diet in patients with chronic renal failure 47
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 47
Resistant hypertension in nondialysis chronic kidney disease. 47
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 47
Inhibition of urea tubular reabsoption by PGE-1 infusion in man 46
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 46
Hypertension in patients on hemodialysis: the role of salt intake. 46
Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells 46
Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice. 46
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 46
Responsiveness to erythropoiesis-stimulating agents in chronic kidney disease: does geography matter? 45
Role of atrial natriuretic factor in renal adaptation to variation of salt intake in humans 45
Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis 45
Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial 45
Epoetin therapy and hemoglobin level variability in nondialysis patients with chronic kidney disease 45
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 45
Medium-term cyclosporin renal dysfunction and its reversibility in rats 45
Diagnostic role of ambulatory blood pressure monitoring in non-dialysis CKD patients 45
Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients. 45
Totale 5.553
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.639
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.639
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.341 315 238 8 14 233 15 251 17 135 50 55 10
2020/20211.951 188 13 236 156 380 8 246 211 14 268 172 59
2021/20221.488 164 1 7 23 533 12 17 32 58 118 124 399
2022/20233.168 256 53 38 326 334 308 8 188 1.505 26 62 64
2023/20241.132 106 39 52 121 410 71 15 25 9 20 85 179
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 10.550